Answers are grounded in this paper and cite their sources.
Observational analysis reveals NME4 upregulation correlates with poor prognosis in clear cell renal cell carcinoma, suggesting a potential biomarker.
NME4 is highly expressed in ccRCC, and its expression levels are significantly associated with patients' clinical characteristics and survival prognosis. Meanwhile, experimental results indicate its important role in tumorigenesis and progression. NME4 has the potential to serve as a biomarker and therapeutic target for ccRCC.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: